News
PACB
1.580
+12.06%
0.170
White House moves to take control of N.I.H. grants, NY Times reports
TipRanks · 3d ago
Weekly Report: what happened at PACB last week (0914-0918)?
Weekly Report · 3d ago
2 Small-Cap Stocks for Long-Term Investors and 1 Facing Headwinds
Barchart · 3d ago
Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing Push
NASDAQ · 4d ago
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today
NASDAQ · 6d ago
Weekly Report: what happened at PACB last week (0907-0911)?
Weekly Report · 09/14 10:05
3 Cash-Burning Stocks We Approach with Caution
Barchart · 09/14 07:00
Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)
TipRanks · 09/11 08:20
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know
NASDAQ · 09/10 22:15
Pacific Biosciences Coverage Assumed by UBS at Neutral
Dow Jones · 09/09 18:18
Pacific Biosciences Price Target Cut to $1.35/Share From $1.50 by UBS
Dow Jones · 09/09 18:18
UBS Assumes Pacific Biosciences at Neutral, Lowers Price Target of $1.35
Benzinga · 09/09 18:08
Pacific Biosciences (PACB) Has a New Rating from UBS
TipRanks · 09/09 10:46
Weekly Report: what happened at PACB last week (0831-0904)?
Weekly Report · 09/07 10:00
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?
NASDAQ · 09/03 17:51
PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference
Barchart · 09/03 15:05
PACB Cuts 2026 Outlook as Clinical Adoption Faces Its Crucial Test
NASDAQ · 09/02 17:55
Weekly Report: what happened at PACB last week (0824-0828)?
Weekly Report · 08/31 10:06
1 of Wall Street’s Favorite Stocks to Own for Decades and 2 We Brush Off
Barchart · 08/26 02:42
Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday
Benzinga · 08/25 14:03
More
Webull provides a variety of real-time PACB stock news. You can receive the latest news about Pacific Biosc through multiple platforms. This information may help you make smarter investment decisions.
About PACB
Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops, and manufactures sequencing solutions. Its products and technology include HiFi long-read sequencing technology, which addresses a set of applications including human germline sequencing, plant and animal sciences, infectious disease, microbiology, oncology, and other applications. Its sequencing technology supports oncology research by enabling analysis of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), providing researchers with insight into cancer biology. It focuses on creating sequencing systems to provide customers with a view of genomes, transcriptomes, and epigenomes. Its customers include academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations (CROs), pharmaceutical companies, and agricultural companies.